{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:08:23Z","timestamp":1788307703063,"version":"build-2803163510"},"reference-count":42,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,7,7]],"date-time":"2009-07-07T00:00:00Z","timestamp":1246924800000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Specialist Pediatric Nursing"],"published-print":{"date-parts":[[2009,7]]},"abstract":"<jats:p><jats:bold>PURPOSE.\u2002<\/jats:bold> The purpose of this article is to review relevant background literature regarding the evidence linking thimerosal\u2010containing vaccine and the measles, mumps, and rubella vaccine to autism.<\/jats:p><jats:p><jats:bold>CONCLUSIONS.\u2002<\/jats:bold> Rigorous scientific studies have not identified links between autism and either thimerosal\u2010containing vaccine or the measles, mumps, and rubella vaccine.<\/jats:p><jats:p><jats:bold>PRACTICE IMPLICATIONS.\u2002<\/jats:bold> Nurses are often in the position of providing advice regarding vaccines in their formal practice areas as well as in their daily lives. Families need current and credible evidence to make decisions for their children. Excellent vaccine information resources are available online.<\/jats:p>","DOI":"10.1111\/j.1744-6155.2009.00194.x","type":"journal-article","created":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T21:31:15Z","timestamp":1247175075000},"page":"166-172","source":"Crossref","is-referenced-by-count":39,"title":["Autism and Vaccination\u2014The Current Evidence"],"prefix":"10.1111","volume":"14","author":[{"given":"Lisa","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joni","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,7,7]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20585"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2007.122937"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.107.5.1147"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.7712"},{"key":"e_1_2_6_6_1","first-page":"241","article-title":"Ten great public health achievements","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"e_1_2_6_7_1","first-page":"996","article-title":"Recommendations regarding the use of vaccines that contain thimerosal as a perservative","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"e_1_2_6_8_1","first-page":"637","article-title":"National, state, and urban area vaccination coverage levels among children aged 19\u201335 months\u2013United States, 2000","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"e_1_2_6_9_1","first-page":"658","article-title":"National, state, and urban area vaccination coverage among children aged 19\u201335 months\u2013United States, 2003","volume":"53","author":"Centers for Disease Control and Prevention","year":"2004","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"e_1_2_6_10_1","first-page":"129","volume-title":"Epidemiology and prevention of vaccine\u2010preventable diseases","author":"Centers for Disease Control and Prevention","year":"2007"},{"key":"e_1_2_6_11_1","first-page":"961","article-title":"National, state, and local area vaccination coverage among children aged 19\u201335 months\u2013United States, 2007","volume":"57","author":"Centers for Disease Control and Prevention","year":"2008","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"e_1_2_6_12_1","first-page":"893","article-title":"Update: measles\u2013United States, January\u2010July 2008","volume":"57","author":"Centers for Disease Control and Prevention","year":"2008","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"e_1_2_6_13_1","unstructured":"Centers for Disease Control and Prevention. (n.d.).Vaccine safety. Vaccine safety datalink (VSD) project. Retrieved October 18 2008 fromhttp:\/\/www.cdc.gov\/vaccinesafety\/vsd"},{"key":"e_1_2_6_14_1","unstructured":"Department of Health and Human Services. (n.d.).VAERS: Vaccine Adverse Event Reporting System. Retrieved October 19 2008 fromhttp:\/\/vaers.hhs.gov\/"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-1262"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.9.1183"},{"key":"e_1_2_6_17_1","first-page":"1071","article-title":"Director's perspective","volume":"55","author":"Foege W.H.","year":"2006","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.108.4.e58"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-2993"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.107.5.e84"},{"key":"e_1_2_6_21_1","volume-title":"Confirmed cases of measles, mumps and rubella 1996\u20132008","author":"Health Protection Agency","year":"2008"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7610.2005.01425.x"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003140"},{"key":"e_1_2_6_24_1","volume-title":"Immunization safety review: Measles\u2010mumps\u2010rubella vaccine and autism","author":"Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention, & Institute of Medicine","year":"2001"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005443726670"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.322.7284.460"},{"key":"e_1_2_6_27_1","first-page":"1","article-title":"General recommendations on immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Kroger A. T.","year":"2006","journal-title":"Morbidity and Mortality Weekly Report Recommendations and Reports"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021134"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001179"},{"key":"e_1_2_6_30_1","volume-title":"MRC review of autism research. Epidemiology and causes","author":"Medical Research Council","year":"2001"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15715-2"},{"key":"e_1_2_6_32_1","volume-title":"NHS immunisation statistics: England: 2004\u201305","author":"National Statistics, T. I. C.","year":"2005"},{"key":"e_1_2_6_33_1","volume-title":"NHS immunisation statistics, England: 2007\u201308","author":"National Statistics, T. I. C.","year":"2008"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.publhealth.28.021406.144007"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-005-0070-1"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17020-7"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-3797(03)00113-2"},{"key":"e_1_2_6_38_1","unstructured":"Thimerosal in Vaccines. (n.d.).Thimerosal as a preservative. Food and Drug Administration. Retrieved October 8 2008 fromhttp:\/\/www.fda.gov\/CBER\/vaccine\/thimerosal.htm#thi"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa071434"},{"key":"e_1_2_6_40_1","unstructured":"U.S. Court of Federal Claims. (n.d.).Autism decisions and background information. Retrieved February 23 2009 fromhttp:\/\/www.uscfc.uscourts.gov\/node\/5026"},{"key":"e_1_2_6_41_1","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1542\/peds.112.5.1039","article-title":"Safety of thimerosal\u2010containing vaccines: A two\u2010phased study of computerized health maintenance organizations databases","volume":"112","author":"Verstraeten T.","year":"2003","journal-title":"Pediatrics"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14471-6"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)11096-0"}],"container-title":["Journal for Specialists in Pediatric Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1744-6155.2009.00194.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1744-6155.2009.00194.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T19:00:58Z","timestamp":1696964458000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1744-6155.2009.00194.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["10.1111\/j.1744-6155.2009.00194.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1744-6155.2009.00194.x","archive":["Portico"],"relation":{},"ISSN":["1539-0136","1744-6155"],"issn-type":[{"value":"1539-0136","type":"print"},{"value":"1744-6155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}